IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,080 | -9.0% | 3,941 | -4.9% | 0.00% | -100.0% |
| Q4 2022 | $26,467 | -93.6% | 4,142 | -90.4% | 0.00% | -88.9% |
| Q3 2022 | $414,000 | -21.0% | 43,168 | -9.0% | 0.01% | -10.0% |
| Q2 2022 | $524,000 | -45.1% | 47,439 | -17.2% | 0.01% | -33.3% |
| Q1 2022 | $954,000 | -46.4% | 57,322 | -38.5% | 0.02% | -40.0% |
| Q4 2021 | $1,779,000 | -23.9% | 93,167 | -1.7% | 0.02% | -30.6% |
| Q3 2021 | $2,337,000 | -3.8% | 94,778 | +1.5% | 0.04% | 0.0% |
| Q2 2021 | $2,430,000 | -0.3% | 93,391 | +21.4% | 0.04% | -5.3% |
| Q1 2021 | $2,437,000 | +26.3% | 76,959 | +85.2% | 0.04% | +18.8% |
| Q4 2020 | $1,929,000 | +977.7% | 41,563 | +665.0% | 0.03% | +966.7% |
| Q3 2020 | $179,000 | +123.8% | 5,433 | +86.3% | 0.00% | +50.0% |
| Q2 2020 | $80,000 | – | 2,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |